Population Pharmacokinetic Study of Amikacin Administered Once or Twice Daily to Febrile, Severely Neutropenic Adults

Once-daily (o.d.) administration of 20 mg of amikacin per kg of body weight to neutropenic patients has been validated by clinical studies, but amikacin pharmacokinetics have been documented only for the 7.5-mg/kg twice-daily (b.i.d.) regimen in this population. In order to determine in neutropenic...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Tod, Michel, Lortholary, Olivier, Seytre, Delphine, Semaoun, Rémi, Uzzan, Bernard, Guillevin, Loïc, Casassus, Philippe, Petitjean, Olivier
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1998
Témata:	Pharmacology
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105554/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9559795/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.4.849
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!